HPV Vaccine Significantly Reduces Cancer Risk in Men and Women

New studies highlight the vaccine's effectiveness in preventing various HPV-related cancers, though vaccination rates remain low among boys.

Research presented at ASCO shows vaccinated men have fewer head and neck cancers compared to unvaccinated men.
The HPV vaccine has been recommended for girls since 2006 and for boys since 2011.
Vaccination rates among boys are significantly lower than those among girls in the U.S.
HPV-related cancers are more common in men, making vaccination crucial for both genders.
Experts emphasize the importance of vaccinating teenagers before they are exposed to the virus.